These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20931336)

  • 1. Multi-model inference of adult and childhood leukaemia excess relative risks based on the Japanese A-bomb survivors mortality data (1950-2000).
    Walsh L; Kaiser JC
    Radiat Environ Biophys; 2011 Mar; 50(1):21-35. PubMed ID: 20931336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent analysis of the radiation risk for leukaemia in children and adults with mortality data (1950-2003) of Japanese A-bomb survivors.
    Kaiser JC; Walsh L
    Radiat Environ Biophys; 2013 Mar; 52(1):17-27. PubMed ID: 23124826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and multi-model inference of excess risks models for radiation-related solid cancer.
    Stabilini A; Hafner L; Walsh L
    Radiat Environ Biophys; 2023 Mar; 62(1):17-34. PubMed ID: 36680572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reanalysis of cancer mortality in Japanese A-bomb survivors exposed to low doses of radiation: bootstrap and simulation methods.
    Dropkin G
    Environ Health; 2009 Dec; 8():56. PubMed ID: 20003238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.
    Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
    Radiat Res; 2017 May; 187(5):513-537. PubMed ID: 28319463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projection of cancer risks from the Japanese atomic bomb survivors to the England and Wales population taking into account uncertainty in risk parameters.
    Little MP; Deltour I; Richardson S
    Radiat Environ Biophys; 2000 Dec; 39(4):241-52. PubMed ID: 11200968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionizing radiation and kidney cancer among Japanese atomic bomb survivors.
    Richardson DB; Hamra G
    Radiat Res; 2010 Jun; 173(6):837-42. PubMed ID: 20518663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
    Preston DL; Shimizu Y; Pierce DA; Suyama A; Mabuchi K
    Radiat Res; 2003 Oct; 160(4):381-407. PubMed ID: 12968934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
    Little MP; Hall P; Charles MW
    Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.
    Preston DL; Cullings H; Suyama A; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K; Kasagi F; Shore RE
    J Natl Cancer Inst; 2008 Mar; 100(6):428-36. PubMed ID: 18334707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of cell inactivation and carcinogenesis in the atomic bomb survivors with applications to the mortality from all solid, stomach and liver cancer.
    Jacob P; Walsh L; Eidemüller M
    Radiat Environ Biophys; 2008 Jul; 47(3):375-88. PubMed ID: 18481074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998.
    Kaiser JC; Jacob P; Meckbach R; Cullings HM
    Radiat Environ Biophys; 2012 Mar; 51(1):1-14. PubMed ID: 21947564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009.
    Cahoon EK; Preston DL; Pierce DA; Grant E; Brenner AV; Mabuchi K; Utada M; Ozasa K
    Radiat Res; 2017 May; 187(5):538-548. PubMed ID: 28323575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for determining weights for excess relative risk and excess absolute risk when applied in the calculation of lifetime risk of cancer from radiation exposure.
    Walsh L; Schneider U
    Radiat Environ Biophys; 2013 Mar; 52(1):135-45. PubMed ID: 23180110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
    Bennett J; Little MP; Richardson S
    Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid cancer incidence in atomic bomb survivors: 1958-1998.
    Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
    Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.